Methadone Maintenance Treatment

Endnotes

1. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC, American Psychiatric Association, 1994.
2. Fischer, B., and Rehm, J. The case for a heroin substitution treatment trial in Canada. Canadian Journal of Public Health, 88(6), 367, 1997.
3. Wall, R., Rehm, J., Fischer, B., Brands, B., Gliksman, L., Stewart, J., Melved, W., Blake, J. Social costs of untreated opioid dependence. Journal of Urban Health, 77 (4), 688-722, 2000.
4. Health Canada. HIV/AIDS among injection drug users in Canada. HIV/AIDS Epi Update, [On-line] May 1999. Bureau of HIV/AIDS, STD and TB Update Series. Laboratory Centre for Disease Control, 1, 1999.
5. As cited in Health Canada. Profile of Hepatitis C & Injection Drug Use in Canada: A Discussion Paper. Prepared for Hepatitis C Prevention, Support & Research Program, Population & Public Health Branch, Health Canada, 2000.
6. For further information refer to: Canadian HIV-AIDS Legal Network. Injection drug use and HIV/AIDS: Legal and ethical issues. Montreal: Author, 11, 1999. Health Canada. Profile of Hepatitis C & Injection Drug Use in Canada: A Discussion Paper. Prepared for Hepatitis C Prevention, Support & Research Program, Population & Public Health Branch, Health Canada, 15-20, 2000.
7. Single, E. et al., as cited in Fischer, B., and Rehm, J. The case for a heroin substitution treatment trial in Canada. Canadian Journal of Public Health, 88(6), 368, 1997.
8. Albert, T., Williams, G., Legowski, B., & Remis, R. The economic burden of HIV/AIDS in Canada. Ottawa: Canadian Policy Research Networks (CPRN), 38, 1998.
9. Lowinson, J.H., Payte, J.T., Salsitz, E., Joseph, H., Marion, I.J., & Dole, V.P. Methadone maintenance. In J.H. Lowinson, J.T. Payte, E. Salsitz, H. Joseph, I.J. Marion, & V.P. Dole (Eds.), Substance Abuse: a comprehensive text (3rd ed., pp. 405-415). Baltimore: Williams and Wilkins, 407, 1997.
10. Health Canada, Dispensing Methadone for the Treatment of Opioid Dependence: Guidelines for Pharmacists. Minister of National Health and Welfare, 1994.
11. Health and Welfare Canada, The Use of Opioids in the Management of Opioid Dependence. Minister of National Health and Welfare, 1992.
12. McGlothin and Anglin, as cited in National Institute on Drug Abuse. Methadone maintenance treatment: Translating research into policy. Bethesda, MD: Author, 4-8, 1995.
13. Simpson and Sells; Hubbard et al.; Simpson and Sells; Ball and Ross, as cited in National Institute on Drug Abuse. Methadone maintenance treatment: Translating research into policy. Bethesda, MD: Author, 4-10, 4-12, 4-14, 1995.
14. Hubbard et al., as cited in National Institute on Drug Abuse. Methadone maintenance treatment: Translating research into policy. Bethesda, MD: Author, 4-15, 1995.
15. McGlothlin and Anglin, as cited in National Institute on Drug Abuse. Methadone maintenance treatment: Translating research into policy. Bethesda, MD: Author, 4-8, 1995.
16. McGlothlin and Anglin,as cited in National Institute on Drug Abuse. Methadone maintenance treatment: Translating research into policy. Bethesda, MD: Author, 4-8,4-16,4-17, 1995.
17. McGlothlin and Anglin, as cited in National Institute on Drug Abuse. Methadone maintenance treatment: Translating research into policy. Bethesda, MD: Author, 4-8, 1995.
18. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA, 280(22), 1938, 1998.
19. Ball and Ross, as cited in National Institute on Drug Abuse. Methadone maintenance treatment: Translating research into policy. Bethesda, MD: Author, 4-22, 1995.
20. Studies reviewed by Ward J., Mattick R.P. & Hall W. The effectiveness of methadone maintenance treatment 2: HIV and infectious hepatitis. In J. Ward, R.P. Mattick, & W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 59-73). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers, 67-68, 1998.
21. For further information refer to: Wells, E., Calsyn, D.A., & Clark, L.L. Retention in methadone maintenance is associated with reductions in different HIV risk behaviours for women and men. American Journal of Drug and Alcohol Abuse, 22 (4), 519, 1996. Longshore, D., Hsieh, S., & Anglin, M.D. Reducing HIV risk behavior among injection drug users: Effect of methadone maintenance treatment on number of sex partners. The International Journal of the Addictions, 29 (6), 754, 1996, 1994.
22. Metzger et al., as cited in National Institute on Drug Abuse. Methadone maintenance treatment: Translating research into policy. Bethesda, MD: Author, 4-19, 4-20, 1995.
23. Novick, D.M. The Impact of Hepatitis C Virus Infection on Methadone Maintenance Treatment. The Mount Sinai Journal of Medicine, 67 (5 & 6), 440, 2000.
24. For further information refer to: Lowinson, J.H., Payte, J.T., Salsitz, E., Joseph, H., Marion, I.J., & Dole, V.P. Methadone maintenance. In J.H. Lowinson, J.T. Payte, E. Salsitz, H. Joseph, I.J. Marion, & V.P. Dole (Eds.), Substance Abuse: a comprehensive text (3rd ed., pp. 405-415). Baltimore: Williams and Wilkins, 409, 1997. Dole, Nyswander and Kreek, as cited in National Institute on Drug Abuse. Methadone maintenance treatment: Translating research into policy. Bethesda, MD: Author, 4-9, 1995.
25. Gearing and Schweitzer, as cited in Brands, B., & Brands, J. (Eds.) Methadone Maintenance: A Physician's Guide to Treatment. Toronto: Addiction Research Foundation, Centre for Addiction and Mental Health, 2, 1998.
26. Simpson and Sells, as cited in National Institute on Drug Abuse. Methadone maintenance treatment: Translating research into policy. Bethesda, MD: Author, 4-18, 1995.
27. Dazord, A., Mino, A., Page, D., & Broers, B. Patients on methadone maintenance treatment in Geneva. Eur Psychiatry, 13, 235, 1998.
28. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA, 280(22), 1939, 1998.
29. Kaltenbach et al., as cited in National Institute on Drug Abus. Methadone maintenance treatment: Translating research into policy. Bethesda, MD: Author, 1-32,1-33, 1995.
30. Simpson and Sells; Ball and Ross, as cited in National Institute on Drug Abuse. Methadone maintenance treatment: Translating research into policy. Bethesda, MD: Author, 4-11,4-14, 1995.
31. Studies by the National Institute on Drug Abuse, as cited in Health Canada. Best practices - substance abuse treatment and rehabilitation. Ottawa: Minister of Public Works and Government Services Canada, 12-13, 1999.
32. Harwood et al., as cited in National Institute on Drug Abus. Methadone maintenance treatment: Translating research into policy. Bethesda, MD: Author, 1-47, 1995.
33. Results of CALDATA study, as cited in Stoller, B.B., and Bigelow, G.E. Regulatory, cost, and policy issues. In E.C. Strain & M.L. Stitzer (Eds.), Methadone treatment for opioid dependence (pp. 15-37). Baltimore: The Johns Hopkins University Press, 24, 1999.
34. Wall, R., Rehm, J., Fischer, B., Brands, B., Gliksman, L., Stewart, J., Melved, W., Blake, J. Social costs of untreated opioid dependence. Journal of Urban Health 77 (4), 688-722, 2000.
35. Dr. David Marsh, Centre for Addiction and Mental Health. Personal communication (November, 2000).
36. Ward, P., & Sutton, M. The effectiveness of methadone maintenance treatment 4: Cost-effectiveness. In J. Ward, R.P. Mattick & W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 91-121). Amsterdam: Overseas Publishers Association, Harwood Academic Publishers, 117, 1998.
37. Rufener et al., as cited in Lowinson, J.H., Payte, J.T., Salsitz, E., Joseph, H., Marion, I.J., & Dole, V.P. Methadone maintenance. In J.H. Lowinson, J.T. Payte, E. Salsitz, H. Joseph, I.J. Marion, & V.P. Dole (Eds). Substance abuse: a comprehensive text (3rd ed., pp. 405-415). Baltimore: Williams and Wilkins, 410, 1997.